(Q39441583)

12 September 2017

title

Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model (English)

1 reference

12 September 2017

0 references

Ulrich Kalinke

5

0 references

author name string

Silke Schüle

1

1 reference

12 September 2017

Stefanie Steidl

2

1 reference

12 September 2017

Sylvia Panitz

3

1 reference

12 September 2017

Cheick Coulibaly

4

1 reference

12 September 2017

Klaus Cichutek

6

1 reference

12 September 2017

Matthias Schweizer

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

2 May 2006

1 reference

12 September 2017

1 reference

12 September 2017

volume

351

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

237-247

1 reference

Strategies for retargeted gene delivery using vectors derived from lentiviruses.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Association of chemokine-mediated block to HIV entry with coreceptor internalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Efficient retroviral vector targeting of carcinoembryonic antigen-positive tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Lentiviruses in gene therapy clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Modified Envelope Glycoproteins to Retarget Retroviral Vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Recent thymic emigrants (CD4+) continuously migrate through lymphoid organs: within the tissue they alter surface molecule expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Envelope-targeted retrovirus vectors transduce melanoma xenografts but not spleen or liver.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Expression of the human CD4 receptor is sufficient for the transduction of murine T-cells with MLV/HIV pseudotyped vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Disturbed CD4+ T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

The murine chemokine receptor CXCR4 is tightly regulated during T cell development and activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Gene therapy: theoretical and bioethical concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

A transient three-plasmid expression system for the production of high titer retroviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Coreceptor Switch of [MLV(SIVagm)] pseudotype vectors by V3-loop exchange.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

MLV/HIV-pseudotyped vectors: a new treatment option for cutaneous t cell lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

Identification of the block in targeted retroviral-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

High-titer packaging cells producing recombinant retroviruses resistant to human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

inferred from DOI database lookup

7 January 2021

based on heuristic

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

inferred from DOI database lookup

7 January 2021

based on heuristic

Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.034

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.03.034

1 reference

12 September 2017

1 reference